重症肌无力
医学
抗体
内科学
乙酰胆碱受体
重症监护室
胃肠病学
儿科
免疫学
受体
作者
Rita Frangiamore,Elena Rinaldi,Fiammetta Vanoli,Francesca Andreetta,Emilio Ciusani,Silvia Bonanno,Lorenzo Maggi,Annamaria Gallone,Anna Colasuonno,Irene Tramacere,Marta Cheli,Alessandro Pinna,Renato Mantegazza,Carlo Antozzi
摘要
Inhibition of the neonatal Fc receptor (FcRn) for IgG is a promising new therapeutic strategy for antibody-mediated disorders. We report our real-life experience with efgartigimod (EFG) in 19 patients with generalized myasthenia gravis (gMG) along a clinical follow-up of 14 months.
科研通智能强力驱动
Strongly Powered by AbleSci AI